HLA-C and cancer: Demethylating agents such as 5-aza-2′-deoxycytidine (5-aza) are known to upregulate MHC-I expression in cancer cells36, thus we treated our clonal cell lines with 5-aza for 72 h to determine whether DNA methylation was a mechanism suppressing MHC expression in the IE1 clone.